首页 > 最新文献

Digital Chinese Medicine最新文献

英文 中文
Mechanism of Bugansan Decoction in ameliorating learning and memory impairment in D-galactose-induced aging rats based on AGEs/RAGE/NF-κB pathway 补肝散汤基于AGEs/RAGE/NF-κB通路改善d -半乳糖致衰老大鼠学习记忆障碍的机制
Q3 Medicine Pub Date : 2023-09-01 DOI: 10.1016/j.dcmed.2023.10.007
Wei Li , Shuo Wang , Jiepeng Wang , Fang Fang , Chaoyi Fang

Objective

To investigate the underlying mechanism of the compound Bugansan Decoction (补肝散, BGSD) in intervening learning and memory in D-galactose (D-gal)-induced aging rats.

Methods

A total of 40 rats were randomly assigned to four groups: control, model, BGSD [14.06 g/(kg·d)], and piracetam [0.4 g/(kg·d)] groups, with 10 rats in each group. D-gal [400 mg/(kg·d)] was injected intraperitoneally to establish the aging rat model. The rats' body weight, water intake, food intake, and gripping strength were recorded each week. The eight-arm maze and step-down test were used to measure the rats' capacity for learning and memory. Liver, thymus, spleen, and brain tissues were weighed to calculate the corresponding organ indices; serum malondialdehyde (MDA) content and superoxide dismutase (SOD) activity were measured. Hematoxylin and eosin (HE) staining was adopted to observe the pathological changes of the hippocampus; enzyme-linked immunosorbent assay (ELISA) was used to detect the levels of tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-1β in the hippocampus. Real-time quantitative polymerase chain reaction (RT-qPCR) was used to detect the expression of receptors for advanced glycation end products (RAGE), nuclear factor-κB (NF-κB), TNF-α, IL-6, and IL-1β mRNA in the hippocampus. Western blot (WB) was employed to detect the expression levels of advanced glycation end products (AGEs), RAGE, and NF-κB protein in the hippocampus.

Results

In D-gal-induced aging rats, BGSD significantly increased food intake, water intake, body weight, gripping strength, and organ indices (P < 0.05), and significantly decreased working memory error (WME), reference memory error (RME), and total memory errors (TE) in an eight-arm maze (P < 0.05). In the step-down test, step-down latency was prolonged and the frequency of errors dropped (P < 0.05). Additionally, BGSD could lessen the harm done to hippocampus neurons, increase serum SOD activity, lower MDA levels, and down-regulate the expression levels of the pro-inflammatory molecules TNF-α, IL-6, and IL-1β (P < 0.05). Further findings showed that BGSD significantly decreased hippocampal AGEs, RAGE, and NF-κB expression (P < 0.05).

Conclusion

By blocking the AGEs/RAGE/NF-κB signaling pathway, BGSD may regulate the neuroinflammatory damage in D-gal-induced aging rats, and thus improve learning and memory.

目的探讨复方补肝散汤干预d -半乳糖(D-gal)诱导衰老大鼠学习记忆的作用机制。方法将40只大鼠随机分为对照组、模型组、BGSD [14.06 g/(kg·d)]组、吡拉西坦[0.4 g/(kg·d)]组,每组10只。腹腔注射d -gal [400 mg/(kg·d)]建立衰老大鼠模型。每周记录大鼠的体重、饮水量、食物摄入量和握力。采用八臂迷宫和降压实验测量大鼠的学习记忆能力。称量肝脏、胸腺、脾脏、脑组织,计算相应脏器指数;测定血清丙二醛(MDA)含量和超氧化物歧化酶(SOD)活性。采用苏木精伊红(HE)染色观察海马的病理变化;采用酶联免疫吸附法(ELISA)检测大鼠海马组织中肿瘤坏死因子(TNF)-α、白细胞介素(IL)-6、IL-1β水平。采用实时定量聚合酶链反应(RT-qPCR)检测海马中晚期糖基化终产物受体(RAGE)、核因子-κB (NF-κB)、TNF-α、IL-6和IL-1β mRNA的表达。采用Western blot (WB)检测海马组织中晚期糖基化终产物(AGEs)、RAGE、NF-κB蛋白的表达水平。结果在d -gal诱导的衰老大鼠中,BGSD显著增加了摄食量、饮水量、体重、抓握力和器官指数(P <0.05),显著降低了八臂迷宫的工作记忆错误(WME)、参考记忆错误(RME)和总记忆错误(TE) (P <0.05)。在降压测试中,降压延迟时间延长,错误频率下降(P <0.05)。BGSD能减轻海马神经元损伤,提高血清SOD活性,降低MDA水平,下调促炎分子TNF-α、IL-6、IL-1β的表达水平(P <0.05)。进一步研究发现,BGSD可显著降低海马AGEs、RAGE和NF-κB的表达(P <0.05)。结论BGSD可通过阻断AGEs/RAGE/NF-κB信号通路,调节d -gal诱导的衰老大鼠神经炎症损伤,从而改善学习记忆功能。
{"title":"Mechanism of Bugansan Decoction in ameliorating learning and memory impairment in D-galactose-induced aging rats based on AGEs/RAGE/NF-κB pathway","authors":"Wei Li ,&nbsp;Shuo Wang ,&nbsp;Jiepeng Wang ,&nbsp;Fang Fang ,&nbsp;Chaoyi Fang","doi":"10.1016/j.dcmed.2023.10.007","DOIUrl":"https://doi.org/10.1016/j.dcmed.2023.10.007","url":null,"abstract":"<div><h3>Objective</h3><p>To investigate the underlying mechanism of the compound Bugansan Decoction (补肝散, BGSD) in intervening learning and memory in D-galactose (D-gal)-induced aging rats.</p></div><div><h3>Methods</h3><p>A total of 40 rats were randomly assigned to four groups: control, model, BGSD [14.06 g/(kg·d)], and piracetam [0.4 g/(kg·d)] groups, with 10 rats in each group. D-gal [400 mg/(kg·d)] was injected intraperitoneally to establish the aging rat model. The rats' body weight, water intake, food intake, and gripping strength were recorded each week. The eight-arm maze and step-down test were used to measure the rats' capacity for learning and memory. Liver, thymus, spleen, and brain tissues were weighed to calculate the corresponding organ indices; serum malondialdehyde (MDA) content and superoxide dismutase (SOD) activity were measured. Hematoxylin and eosin (HE) staining was adopted to observe the pathological changes of the hippocampus; enzyme-linked immunosorbent assay (ELISA) was used to detect the levels of tumor necrosis factor (TNF)-<em>α</em>, interleukin (IL)-6, and IL-1<em>β</em> in the hippocampus. Real-time quantitative polymerase chain reaction (RT-qPCR) was used to detect the expression of receptors for advanced glycation end products (RAGE), nuclear factor-<em>κ</em>B (NF-<em>κ</em>B), TNF-<em>α</em>, IL-6, and IL-1<em>β</em> mRNA in the hippocampus. Western blot (WB) was employed to detect the expression levels of advanced glycation end products (AGEs), RAGE, and NF-<em>κ</em>B protein in the hippocampus.</p></div><div><h3>Results</h3><p>In D-gal-induced aging rats, BGSD significantly increased food intake, water intake, body weight, gripping strength, and organ indices (<em>P</em> &lt; 0.05), and significantly decreased working memory error (WME), reference memory error (RME), and total memory errors (TE) in an eight-arm maze (<em>P</em> &lt; 0.05). In the step-down test, step-down latency was prolonged and the frequency of errors dropped (<em>P</em> &lt; 0.05). Additionally, BGSD could lessen the harm done to hippocampus neurons, increase serum SOD activity, lower MDA levels, and down-regulate the expression levels of the pro-inflammatory molecules TNF-<em>α</em>, IL-6, and IL-1<em>β</em> (<em>P</em> &lt; 0.05). Further findings showed that BGSD significantly decreased hippocampal AGEs, RAGE, and NF-<em>κ</em>B expression (<em>P</em> &lt; 0.05).</p></div><div><h3>Conclusion</h3><p>By blocking the AGEs/RAGE/NF-<em>κ</em>B signaling pathway, BGSD may regulate the neuroinflammatory damage in D-gal-induced aging rats, and thus improve learning and memory.</p></div>","PeriodicalId":33578,"journal":{"name":"Digital Chinese Medicine","volume":"6 3","pages":"Pages 317-327"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589377723000575/pdfft?md5=c63d1bd794c0e7b3196b229a4a6129e5&pid=1-s2.0-S2589377723000575-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138334796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of carbonization processing on quality control, chemical compositions, and pharmacological mechanism of Ganjiang (Zingiberis Rhizoma) 炭化工艺对甘姜质量控制、化学成分及药理机制的影响
Q3 Medicine Pub Date : 2023-09-01 DOI: 10.1016/j.dcmed.2023.10.009
Zhou Yiqun , Wu Ping , Tang Yu , Liu Wenlong , Shi Jilian , He Fuyuan

Ganjiang (Zingiberis Rhizoma, ZR) and Jiangtan (Carbonized Zingiberis Rhizoma, CZR) have long been used in traditional Chinese medicine (TCM) with a rich history in the treatment of various ailments. While ZR and CZR obviously stem from the same botanical source, their attributes, chemical compositions, pharmacological behaviors, and clinical applications are different owing to variations in the extent of drying and processing they undergo. In this paper, data pertaining to ZR and CZR were retrieved from databases including China National Knowledge Infrastructure (CNKI), PubMed, Web of Science, and Google Scholar. These sources were scrutinized to elucidate the distinctions between ZR and CZR arising from carbonization processing in terms of their ethnopharmacology, quality control, chemical compositions, biological activities, pharmacological mechanisms, and clinical uses. In this study, a total of 56 chemical constituents were identified and isolated from ZR and CZR, which primarily encompassed volatile oils, gingerols, and diphenylheptane compounds. CZR's pharmacological effects include hemostatic, anti-oxidant, analgesic, antibacterial, anti-cancer, and other biological activities. ZR has pungent and warm properties. It is a Yang-supplementing herbal medicine for ailments exacerbated by cold or damp climatic influences. CZR is a product of ZR after undergoing high temperature, with diminished intensity of its pungent and warm attributes. This change leads to a more gradual treatment efficacy, renowned hemostatic effects and its ability to gently invigorate the spleen and effectively alleviate diarrhea. Currently, research on the pharmacological mechanism of CZR is mainly focused on the effects of CZR on coagulation and fibrinolysis. Although the healing effect of CZR has long been known, and some correlation has been found between the changing composition and the changing color of the decoctions, people still lack relatively clear processing mechanisms to reflect the characteristics and specific quality standards of the ingredients of CZR's hemostatic effect. This review provides a systematic summary on quality control, chemical composition, ethnopharmacology, and pharmacology of CZR, offering novel perspectives for advancing the exploration of additional carbonized herbal medicine and fostering their application in clinical settings.

甘姜(姜黄,ZR)和姜谭(碳化姜黄,CZR)在中药中使用已久,在治疗各种疾病方面有着悠久的历史。虽然ZR和CZR显然来自相同的植物来源,但由于干燥和加工程度的不同,它们的属性、化学成分、药理行为和临床应用都不同。本文从中国知网(CNKI)、PubMed、Web of Science和Google Scholar等数据库中检索ZR和CZR相关数据。对这些来源进行了仔细审查,以阐明碳化加工产生的ZR和CZR在民族药理学,质量控制,化学成分,生物活性,药理机制和临床用途方面的区别。在本研究中,从ZR和CZR中共鉴定分离到56个化学成分,主要包括挥发油、姜辣素和二苯庚烷类化合物。CZR的药理作用包括止血、抗氧化、镇痛、抗菌、抗癌等生物活性。ZR有辛辣和温暖的性质。它是一种补阳草药,用于治疗因寒冷或潮湿的气候影响而加剧的疾病。CZR是ZR经过高温后的产物,其刺激性和温暖性减弱。这种变化导致了更渐进的治疗效果,著名的止血效果和它的能力温和地健脾和有效地缓解腹泻。目前,对CZR药理机制的研究主要集中在CZR对凝血和纤溶的作用。虽然CZR的治疗作用早已为人所知,并且发现其成分变化与汤剂颜色变化之间存在一定的相关性,但人们仍然缺乏相对明确的加工机制来反映CZR止血作用成分的特点和具体的质量标准。本文就其质量控制、化学成分、民族药理学、药理学等方面的研究进展进行了系统的综述,为进一步开发中药炭化制剂和促进其临床应用提供了新的思路。
{"title":"Effects of carbonization processing on quality control, chemical compositions, and pharmacological mechanism of Ganjiang (Zingiberis Rhizoma)","authors":"Zhou Yiqun ,&nbsp;Wu Ping ,&nbsp;Tang Yu ,&nbsp;Liu Wenlong ,&nbsp;Shi Jilian ,&nbsp;He Fuyuan","doi":"10.1016/j.dcmed.2023.10.009","DOIUrl":"https://doi.org/10.1016/j.dcmed.2023.10.009","url":null,"abstract":"<div><p>Ganjiang (Zingiberis Rhizoma, ZR) and Jiangtan (Carbonized Zingiberis Rhizoma, CZR) have long been used in traditional Chinese medicine (TCM) with a rich history in the treatment of various ailments. While ZR and CZR obviously stem from the same botanical source, their attributes, chemical compositions, pharmacological behaviors, and clinical applications are different owing to variations in the extent of drying and processing they undergo. In this paper, data pertaining to ZR and CZR were retrieved from databases including China National Knowledge Infrastructure (CNKI), PubMed, Web of Science, and Google Scholar. These sources were scrutinized to elucidate the distinctions between ZR and CZR arising from carbonization processing in terms of their ethnopharmacology, quality control, chemical compositions, biological activities, pharmacological mechanisms, and clinical uses. In this study, a total of 56 chemical constituents were identified and isolated from ZR and CZR, which primarily encompassed volatile oils, gingerols, and diphenylheptane compounds. CZR's pharmacological effects include hemostatic, anti-oxidant, analgesic, antibacterial, anti-cancer, and other biological activities. ZR has pungent and warm properties. It is a Yang-supplementing herbal medicine for ailments exacerbated by cold or damp climatic influences. CZR is a product of ZR after undergoing high temperature, with diminished intensity of its pungent and warm attributes. This change leads to a more gradual treatment efficacy, renowned hemostatic effects and its ability to gently invigorate the spleen and effectively alleviate diarrhea. Currently, research on the pharmacological mechanism of CZR is mainly focused on the effects of CZR on coagulation and fibrinolysis. Although the healing effect of CZR has long been known, and some correlation has been found between the changing composition and the changing color of the decoctions, people still lack relatively clear processing mechanisms to reflect the characteristics and specific quality standards of the ingredients of CZR's hemostatic effect. This review provides a systematic summary on quality control, chemical composition, ethnopharmacology, and pharmacology of CZR, offering novel perspectives for advancing the exploration of additional carbonized herbal medicine and fostering their application in clinical settings.</p></div>","PeriodicalId":33578,"journal":{"name":"Digital Chinese Medicine","volume":"6 3","pages":"Pages 341-356"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589377723000599/pdfft?md5=240a119c27f4076e0379025406642fa3&pid=1-s2.0-S2589377723000599-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138395701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protective effects of ginsenosides on macrophages subjected to simulated weightlessness 人参皂苷对模拟失重巨噬细胞的保护作用
Q3 Medicine Pub Date : 2023-09-01 DOI: 10.1016/j.dcmed.2023.10.004
Boye Li , Tian Chen , Enhui Ji , Ying Chen , Qin Hu , Qingyan Li

Objective

To investigate the evolution of inflammation under conditions and the effects of ginsenosides on macrophages subjected to the simulated weightlessness, with the aim of mitigating the inflammation.

Methods

Initially, genes related to weightlessness, inflammation, and immunity were identified in the GeneCards database. Then, Search Tool for the Retrieval of Interaction Gene/Proteins (STRING) protein network analysis was conducted to determine the core targets involved in the weightlessness-induced inflammation. Subsequently, Label-Free Quantitative (LFQ) proteomics was carried out to discern the distinctive genes within ginsenoside-treated Tohoku Hospital Pediatrics-1 (THP-1) cells. Next, utilizing the outcomes of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses, the biological processes and signaling pathways in which ginsenosides predominately engaged were scrutinized, and the primary targets of ginsenosides in combating weightlessness-induced inflammation were examined. Finally, enzyme-linked immunosorbent assay (ELISA) was performed to detect the secretion levels of interleukin (IL)-1β, IL-6, IL-8, and tumor necrosis factor (TNF)-α from lipopolysaccharide (LPS)-induced THP-1 cells under simulated weightlessness conditions, as well as during the weightlessness recovery period following treatment with ginsenosides.

Results

A total of 2 933 genes associated with inflammation, 425 genes linked to weightlessness, and 4 564 genes connected to immunity were retrieved from the GeneCards database. Protein-protein interaction (PPI) networks were generated to identify pivotal targets associated with weightlessness-induced inflammation such as IL-1β, IL-6, TNF, and albumin (ALB). It was found that ginsenosides primarily participated in the regulation of various inflammation-related signaling pathways and pathways related to pathogenic microorganism infections. Moreover, it has a significant impact on the expression of proteins such as cluster of differentiation 40 (CD40), IL-1β, and poly ADP-ribose polymerase 1 (PARP1). As revealed in the simulated weightlessness cell test, ginsenosides exhibited a remarkable capacity to attenuate the secretion of inflammatory factors, specifically IL-6 and TNF-α (P < 0.000 1), in THP-1 macrophages following induction by LPS under simulated weightlessness conditions. In addition, it reduced the secretion of IL-1β, IL-6, IL-8, and TNF-α (P < 0.000 1) during the weightlessness recovery phase.

Conclusion

Weightlessness can disrupt several inflammation-related signaling pathways, but ginsenosides were shown to mitigate the release of various inflammatory factors in macrophages subjected to simulated weightlessness, thereby exerting a protective role against inflammation. This study has laid a theoretic

目的探讨模拟失重条件下巨噬细胞炎症的演变及人参皂苷对巨噬细胞炎症的影响,以期达到减轻炎症的目的。方法首先,在GeneCards数据库中确定与失重、炎症和免疫相关的基因。然后,使用Search Tool for the Retrieval of Interaction Gene/Proteins (STRING)蛋白网络分析,确定参与失重诱导炎症的核心靶点。随后,进行无标签定量(LFQ)蛋白质组学研究,以识别人参皂苷处理的东北医院儿科-1 (THP-1)细胞中的独特基因。接下来,利用基因本体(GO)和京都基因与基因组百科全书(KEGG)富集分析的结果,仔细检查了人参皂苷主要参与的生物过程和信号通路,并检查了人参皂苷在对抗失重诱导炎症中的主要靶点。最后,采用酶联免疫吸附法(ELISA)检测脂多糖(LPS)诱导的THP-1细胞在模拟失重条件下以及人参皂苷处理后失重恢复期的白细胞介素(IL)-1β、IL-6、IL-8和肿瘤坏死因子(TNF)-α的分泌水平。结果从GeneCards数据库中检索到与炎症相关的基因2 933个,与失重相关的基因425个,与免疫相关的基因4 564个。生成蛋白-蛋白相互作用(PPI)网络,以确定与失重诱导炎症相关的关键靶点,如IL-1β、IL-6、TNF和白蛋白(ALB)。研究发现,人参皂苷主要参与调节多种炎症相关信号通路和病原微生物感染相关通路。此外,它对分化簇40 (CD40)、IL-1β和聚adp核糖聚合酶1 (PARP1)等蛋白的表达也有显著影响。在模拟失重细胞试验中,人参皂苷显示出显著的降低炎症因子分泌的能力,特别是IL-6和TNF-α (P <0.000 1),在模拟失重条件下LPS诱导的THP-1巨噬细胞中。此外,它还能降低IL-1β、IL-6、IL-8和TNF-α的分泌(P <0.000 1)在失重恢复阶段。结论失重可破坏几种炎症相关的信号通路,但人参皂苷可减轻模拟失重巨噬细胞中各种炎症因子的释放,从而发挥抗炎症的保护作用。本研究为进一步探索人参皂苷在失重环境下抗LPS诱导炎症的潜在应用奠定了理论基础。
{"title":"Protective effects of ginsenosides on macrophages subjected to simulated weightlessness","authors":"Boye Li ,&nbsp;Tian Chen ,&nbsp;Enhui Ji ,&nbsp;Ying Chen ,&nbsp;Qin Hu ,&nbsp;Qingyan Li","doi":"10.1016/j.dcmed.2023.10.004","DOIUrl":"https://doi.org/10.1016/j.dcmed.2023.10.004","url":null,"abstract":"<div><h3>Objective</h3><p>To investigate the evolution of inflammation under conditions and the effects of ginsenosides on macrophages subjected to the simulated weightlessness, with the aim of mitigating the inflammation.</p></div><div><h3>Methods</h3><p>Initially, genes related to weightlessness, inflammation, and immunity were identified in the GeneCards database. Then, Search Tool for the Retrieval of Interaction Gene/Proteins (STRING) protein network analysis was conducted to determine the core targets involved in the weightlessness-induced inflammation. Subsequently, Label-Free Quantitative (LFQ) proteomics was carried out to discern the distinctive genes within ginsenoside-treated Tohoku Hospital Pediatrics-1 (THP-1) cells. Next, utilizing the outcomes of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses, the biological processes and signaling pathways in which ginsenosides predominately engaged were scrutinized, and the primary targets of ginsenosides in combating weightlessness-induced inflammation were examined. Finally, enzyme-linked immunosorbent assay (ELISA) was performed to detect the secretion levels of interleukin (IL)-1<em>β</em>, IL-6, IL-8, and tumor necrosis factor (TNF)-<em>α</em> from lipopolysaccharide (LPS)-induced THP-1 cells under simulated weightlessness conditions, as well as during the weightlessness recovery period following treatment with ginsenosides.</p></div><div><h3>Results</h3><p>A total of 2 933 genes associated with inflammation, 425 genes linked to weightlessness, and 4 564 genes connected to immunity were retrieved from the GeneCards database. Protein-protein interaction (PPI) networks were generated to identify pivotal targets associated with weightlessness-induced inflammation such as IL-1<em>β</em>, IL-6, TNF, and albumin (ALB). It was found that ginsenosides primarily participated in the regulation of various inflammation-related signaling pathways and pathways related to pathogenic microorganism infections. Moreover, it has a significant impact on the expression of proteins such as cluster of differentiation 40 (CD40), IL-1<em>β</em>, and poly ADP-ribose polymerase 1 (PARP1). As revealed in the simulated weightlessness cell test, ginsenosides exhibited a remarkable capacity to attenuate the secretion of inflammatory factors, specifically IL-6 and TNF-<em>α</em> (<em>P</em> &lt; 0.000 1), in THP-1 macrophages following induction by LPS under simulated weightlessness conditions. In addition, it reduced the secretion of IL-1<em>β</em>, IL-6, IL-8, and TNF-<em>α</em> (<em>P</em> &lt; 0.000 1) during the weightlessness recovery phase.</p></div><div><h3>Conclusion</h3><p>Weightlessness can disrupt several inflammation-related signaling pathways, but ginsenosides were shown to mitigate the release of various inflammatory factors in macrophages subjected to simulated weightlessness, thereby exerting a protective role against inflammation. This study has laid a theoretic","PeriodicalId":33578,"journal":{"name":"Digital Chinese Medicine","volume":"6 3","pages":"Pages 285-294"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S258937772300054X/pdfft?md5=2927d948d79bc841ab1e0e50f568ca24&pid=1-s2.0-S258937772300054X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138395699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patents research and development prospects of spleen-invigorating health food with the homology of medicine and food from 2000 to 2022: a bibliometric analysis 2000 - 2022年药食同源健脾保健食品专利研究与发展前景:文献计量学分析
Q3 Medicine Pub Date : 2023-09-01 DOI: 10.1016/j.dcmed.2023.10.010
Liu Ping , Fang Rui , He Jiawei , Li Ze , Zhou Yue , Yang Yong , Cheng Shaowu

[Objective]

To analyze the current status and development trends of the patents of spleen-invigorating health food with the homology of medicine and food in China, and to provide ideas and references for the research and development of traditional Chinese medicine (TCM) spleen-invigorating health food with the homology of medicine and food.

[Methods]

The State Administration for Market Regulation website’s “Special Food Information Query Platform” and the incoPat global patent database were searched in this study. Based on the methods of bibliometrics, the registered health food and patents related to spleen-invigorating health food with the homology of medicine and food in China were sorted out. Furthermore, the research and development numbers, provinces, institutions, technology and efficacy classification, major drugs, active ingredients and others of invigorating spleen health food in China were analyzed, and filtered patent data were visualized and analyzed by R programming language and CytoScape software.

[Results]

A total of 285 patents of health food with the homology of medicine and food for invigorating spleen were included and analyzed. From 2012, the patent registration numbers of these spleen-invigorating health food with the homology of medicine and food increased significantly in China. Over the past 20 years, the top five provinces in terms of patent disclosures were Guangdong, Anhui, Jiangsu, Shandong, and Guangxi. It was found that the technical efficacy of over 20 patents was described as “immune enhancement” “digestion” “disease prevention”, etc. Patent applications were mainly aimed at the research and development of the preservation of food or ingredients, the specific therapeutic activity of compounds, and pharmaceutical preparations, which were led by corporation research and development registrations, and supplemented by applications from research institutions and individuals. Among the 285 patents, the top 10 raw materials of spleen-invigorating health food with the homology of medicine and food were Shanyao (Dioscoreae Rhizoma), Fuling (Poria), Shanzha (Crataegi Fructus), Baizhu (Atractylodis Macrocephalae Rhizoma), Chenpi (Citri Reticulatae Pericarpium), Dazao (Jujubae Fructus), Gancao (Glycyrrhizae Radix et Rhizoma), Fengmi (Mel), Maiya (Hordei Fructus Germinatus), and Dangshen (Salviae Miltiorrhizae Radix et Rhizoma). The main functions were to nourish spleen and replenish Qi, invigorate spleen and benefit lungs, nourish blood and promote fluid production, and nourish spleen and stomach.

[Conclusion]

The main drug composition and functional components of spleen-invigorating health food with the homology of medicine and food are relatively clear, and the technical effects of invigorating the spleen and stomach, eliminating accumulation of food, and enhancing immunity are highly targeted. This paper provides evidence for the res

【目的】分析国内药食同源性健脾保健食品专利的现状及发展趋势,为中药药食同源性健脾保健食品的研发提供思路和参考。【方法】检索国家市场监督管理总局网站“特种食品信息查询平台”和incoPat全球专利数据库。运用文献计量学方法,对国内药食同源的健脾保健食品相关注册保健食品及专利进行梳理。分析国内健脾保健食品的研发数量、省份、机构、技术及功效分类、主要药物、有效成分等,并通过R编程语言和CytoScape软件对过滤后的专利数据进行可视化分析。【结果】共纳入健脾药食同源的保健食品专利285项。从2012年开始,这些药食同源的健脾保健食品在中国的专利注册量显著增加。在过去20年中,专利披露数量排名前五的省份分别是广东、安徽、江苏、山东和广西。发现20多项专利的技术功效被描述为“增强免疫”“消化”“预防疾病”等。专利申请主要针对食品或配料的保鲜、化合物的特定治疗活性和药物制剂的研发,以企业研发注册为主,研究机构和个人申请为辅。285项专利中,药食同源性排在前10位的健脾保健食品原料分别是山药(薯蓣)、茯苓(茯苓)、山楂(山楂)、白术(苍术)、陈皮(柑橘皮)、大枣(枣子)、甘草(甘草)、枫蜜(Mel)、麦芽(黑迭子)、砀参(丹参)。主要功能是补脾益气、健脾益肺、补血益液、养脾养胃。【结论】药食同源的健脾保健食品的主要药物成分和功能成分较为明确,健脾胃、祛食积、增强免疫的技术效果针对性强。为今后药食同源的健脾保健食品的研发、机理研究和工艺改进提供依据。
{"title":"Patents research and development prospects of spleen-invigorating health food with the homology of medicine and food from 2000 to 2022: a bibliometric analysis","authors":"Liu Ping ,&nbsp;Fang Rui ,&nbsp;He Jiawei ,&nbsp;Li Ze ,&nbsp;Zhou Yue ,&nbsp;Yang Yong ,&nbsp;Cheng Shaowu","doi":"10.1016/j.dcmed.2023.10.010","DOIUrl":"https://doi.org/10.1016/j.dcmed.2023.10.010","url":null,"abstract":"<div><h3>[Objective]</h3><p>To analyze the current status and development trends of the patents of spleen-invigorating health food with the homology of medicine and food in China, and to provide ideas and references for the research and development of traditional Chinese medicine (TCM) spleen-invigorating health food with the homology of medicine and food.</p></div><div><h3>[Methods]</h3><p>The State Administration for Market Regulation website’s “Special Food Information Query Platform” and the incoPat global patent database were searched in this study. Based on the methods of bibliometrics, the registered health food and patents related to spleen-invigorating health food with the homology of medicine and food in China were sorted out. Furthermore, the research and development numbers, provinces, institutions, technology and efficacy classification, major drugs, active ingredients and others of invigorating spleen health food in China were analyzed, and filtered patent data were visualized and analyzed by R programming language and CytoScape software.</p></div><div><h3>[Results]</h3><p>A total of 285 patents of health food with the homology of medicine and food for invigorating spleen were included and analyzed. From 2012, the patent registration numbers of these spleen-invigorating health food with the homology of medicine and food increased significantly in China. Over the past 20 years, the top five provinces in terms of patent disclosures were Guangdong, Anhui, Jiangsu, Shandong, and Guangxi. It was found that the technical efficacy of over 20 patents was described as “immune enhancement” “digestion” “disease prevention”, etc. Patent applications were mainly aimed at the research and development of the preservation of food or ingredients, the specific therapeutic activity of compounds, and pharmaceutical preparations, which were led by corporation research and development registrations, and supplemented by applications from research institutions and individuals. Among the 285 patents, the top 10 raw materials of spleen-invigorating health food with the homology of medicine and food were Shanyao (Dioscoreae Rhizoma), Fuling (Poria), Shanzha (Crataegi Fructus), Baizhu (Atractylodis Macrocephalae Rhizoma), Chenpi (Citri Reticulatae Pericarpium), Dazao (Jujubae Fructus), Gancao (Glycyrrhizae Radix et Rhizoma), Fengmi (Mel), Maiya (Hordei Fructus Germinatus), and Dangshen (Salviae Miltiorrhizae Radix et Rhizoma). The main functions were to nourish spleen and replenish Qi, invigorate spleen and benefit lungs, nourish blood and promote fluid production, and nourish spleen and stomach.</p></div><div><h3>[Conclusion]</h3><p>The main drug composition and functional components of spleen-invigorating health food with the homology of medicine and food are relatively clear, and the technical effects of invigorating the spleen and stomach, eliminating accumulation of food, and enhancing immunity are highly targeted. This paper provides evidence for the res","PeriodicalId":33578,"journal":{"name":"Digital Chinese Medicine","volume":"6 3","pages":"Pages 357-368"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589377723000605/pdfft?md5=13803e9c59e44f5eb5869e25209f888b&pid=1-s2.0-S2589377723000605-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138395702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolic profile changes of kidney aging and protective effects of Polygonatum sibiricum polysaccharides on D-galactose-induced aging mice 黄精多糖对d -半乳糖诱导衰老小鼠肾脏代谢谱的改变及保护作用
Q3 Medicine Pub Date : 2023-09-01 DOI: 10.1016/j.dcmed.2023.10.008
Di Zhao , Sharmeen Fayyaz , Ziyang Yi , Zhao Liu , Yan Wang , Ping Cai , Wei He

Objective

To investigate the metabolic trajectory of kidney aging and the effects of Polygonatum sibiricum polysaccharides (PSP) against kidney aging in D-galactose (D-gal)-induced aging mice, based on ultra-performance liquid chromatography/Q-Exactive Orbitrap mass spectrometry (UPLC-Q-Exactive MS/MS).

Methods

A total of 36 C57 BL/6J mice were randomly allocated to six groups: control (CON), model (MOD), PSP low-dose (PSP-L), PSP medium-dose (PSP-M), PSP high-dose (PSP-H), and positive drug ascorbic acid (VC) groups. To create models of aging mice, D-gal was intraperitoneally administered to all other groups of mice except the CON group. After modeling, the appropriate Chinese medicine [PSP-L: 150 mg/(kg·d), PSP-M: 300 mg/(kg·d), PSP-H: 600 mg/(kg·d)] or positive drug [ascorbic acid, 300 mg/(kg·d)] was administered for intervention. Key markers of renal function in urine and serum of mice in each group, such as creatinine (Crea), urea nitrogen (BUN), and uric acid (UA) levels, as well as key indicators of oxidative stress in serum and kidney, including superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA), and glutathione peroxidase (GSH-Px) were determined to validate the successful establishment of kidney aging models and to estimate the effects of PSP. Hematoxylin and eosin (HE), periodic acid Schiff (PAS), and β-galactosidase staining were used to assess the renal pathological changes. The metabolic profiles of serum, kidney, and urine samples from CON, MOD, and PSP-H groups were analyzed by UPLC-Q-Exactive MS/MS, and pattern recognition methods were used to outline the metabolic trajectory of kidney aging and to identify the characteristic metabolites.

Results

Age-related alterations in renal histopathology and impaired renal function in mice were also associated with oxidative stress indicators. Following the injection of PSP [PSP-H: 600 mg/(kg·d)], the pathological indices associated with aging were adjusted to normal levels, renal function and oxidative stress were improved in aging mice, and renal pathological damage was markedly improved. Meanwhile, the potential biomarkers were identified by UPLC-Q-Exactive MS/MS analysis and were further analyzed to form related metabolic pathways, with P < 0.05 as a threshold. The results showed that purine, sphingolipid, glycerophospholipid, tryptophan, and riboflavin metabolisms were the main metabolic pathways associated with aging. After administration of PSP, these pathological indices returned to normal levels, and biomarkers related to the aging process, such as adenosine monophosphate (AMP), tryptophan, and 5-hydroxytryptophan, also demonstrated, to some degree, reverse regulation (promoting synthesis).

Conclusion

Metabolomics methods based on UPLC-Q-Exactive MS/MS and multivariate statistical analysis can be adopted to establish metabolic profiles in aging mic

目的采用超高效液相色谱-Q-Exactive质谱(UPLC-Q-Exactive MS/MS)技术,研究黄精多糖(PSP)对d -半乳糖(D-gal)诱导衰老小鼠肾脏衰老的代谢轨迹及抗衰老作用。方法将36只C57 BL/6J小鼠随机分为对照组(CON)、模型组(MOD)、PSP低剂量组(PSP- l)、PSP中剂量组(PSP- m)、PSP高剂量组(PSP- h)和抗坏血酸阳性药物组(VC)。为了建立衰老小鼠模型,除CON组外,其余各组小鼠均腹腔注射D-gal。造模后给予相应中药[PSP-L: 150 mg/(kg·d), PSP-M: 300 mg/(kg·d), PSP-H: 600 mg/(kg·d)]或阳性药物[抗坏血酸,300 mg/(kg·d)]进行干预。测定各组小鼠尿液和血清中肌酸酐(Crea)、尿素氮(BUN)、尿酸(UA)等关键肾功能指标,以及血清和肾脏中氧化应激关键指标超氧化物歧化酶(SOD)、过氧化氢酶(CAT)、丙二醛(MDA)、谷胱甘肽过氧化物酶(GSH-Px)等指标,验证肾脏衰老模型的成功建立,并评价PSP的作用。采用苏木精伊红(HE)染色、周期性酸希夫(PAS)染色、β-半乳糖苷酶染色评价肾脏病理变化。采用UPLC-Q-Exactive MS/MS分析CON、MOD和PSP-H组的血清、肾脏和尿液代谢谱,并采用模式识别方法勾勒出肾脏衰老的代谢轨迹,识别出特征代谢物。结果小鼠肾组织病理学的年龄相关改变和肾功能受损也与氧化应激指标相关。注射PSP [PSP- h: 600 mg/(kg·d)]后,与衰老相关的病理指标调整至正常水平,衰老小鼠的肾功能和氧化应激得到改善,肾脏病理损伤明显改善。同时,通过UPLC-Q-Exactive MS/MS分析鉴定潜在的生物标志物,并进一步分析形成相关的代谢途径,其中P <0.05为阈值。结果表明,嘌呤、鞘脂、甘油磷脂、色氨酸和核黄素代谢是与衰老相关的主要代谢途径。给药后,这些病理指标恢复到正常水平,与衰老过程相关的生物标志物,如腺苷单磷酸腺苷(AMP)、色氨酸和5-羟色氨酸,也在一定程度上表现出反向调节(促进合成)。结论基于UPLC-Q-Exactive MS/MS和多元统计分析的代谢组学方法可以建立衰老小鼠的代谢谱。PSP通过干扰肾脏中的嘌呤、鞘脂、甘油磷脂、色氨酸和核黄素代谢来防止肾脏衰老。
{"title":"Metabolic profile changes of kidney aging and protective effects of Polygonatum sibiricum polysaccharides on D-galactose-induced aging mice","authors":"Di Zhao ,&nbsp;Sharmeen Fayyaz ,&nbsp;Ziyang Yi ,&nbsp;Zhao Liu ,&nbsp;Yan Wang ,&nbsp;Ping Cai ,&nbsp;Wei He","doi":"10.1016/j.dcmed.2023.10.008","DOIUrl":"https://doi.org/10.1016/j.dcmed.2023.10.008","url":null,"abstract":"<div><h3>Objective</h3><p>To investigate the metabolic trajectory of kidney aging and the effects of <em>Polygonatum sibiricum</em> polysaccharides (PSP) against kidney aging in D-galactose (D-gal)-induced aging mice, based on ultra-performance liquid chromatography/Q-Exactive Orbitrap mass spectrometry (UPLC-Q-Exactive MS/MS).</p></div><div><h3>Methods</h3><p>A total of 36 C57 BL/6J mice were randomly allocated to six groups: control (CON), model (MOD), PSP low-dose (PSP-L), PSP medium-dose (PSP-M), PSP high-dose (PSP-H), and positive drug ascorbic acid (VC) groups. To create models of aging mice, D-gal was intraperitoneally administered to all other groups of mice except the CON group. After modeling, the appropriate Chinese medicine [PSP-L: 150 mg/(kg·d), PSP-M: 300 mg/(kg·d), PSP-H: 600 mg/(kg·d)] or positive drug [ascorbic acid, 300 mg/(kg·d)] was administered for intervention. Key markers of renal function in urine and serum of mice in each group, such as creatinine (Crea), urea nitrogen (BUN), and uric acid (UA) levels, as well as key indicators of oxidative stress in serum and kidney, including superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA), and glutathione peroxidase (GSH-Px) were determined to validate the successful establishment of kidney aging models and to estimate the effects of PSP. Hematoxylin and eosin (HE), periodic acid Schiff (PAS), and <em>β</em>-galactosidase staining were used to assess the renal pathological changes. The metabolic profiles of serum, kidney, and urine samples from CON, MOD, and PSP-H groups were analyzed by UPLC-Q-Exactive MS/MS, and pattern recognition methods were used to outline the metabolic trajectory of kidney aging and to identify the characteristic metabolites.</p></div><div><h3>Results</h3><p>Age-related alterations in renal histopathology and impaired renal function in mice were also associated with oxidative stress indicators. Following the injection of PSP [PSP-H: 600 mg/(kg·d)], the pathological indices associated with aging were adjusted to normal levels, renal function and oxidative stress were improved in aging mice, and renal pathological damage was markedly improved. Meanwhile, the potential biomarkers were identified by UPLC-Q-Exactive MS/MS analysis and were further analyzed to form related metabolic pathways, with <em>P</em> &lt; 0.05 as a threshold. The results showed that purine, sphingolipid, glycerophospholipid, tryptophan, and riboflavin metabolisms were the main metabolic pathways associated with aging. After administration of PSP, these pathological indices returned to normal levels, and biomarkers related to the aging process, such as adenosine monophosphate (AMP), tryptophan, and 5-hydroxytryptophan, also demonstrated, to some degree, reverse regulation (promoting synthesis).</p></div><div><h3>Conclusion</h3><p>Metabolomics methods based on UPLC-Q-Exactive MS/MS and multivariate statistical analysis can be adopted to establish metabolic profiles in aging mic","PeriodicalId":33578,"journal":{"name":"Digital Chinese Medicine","volume":"6 3","pages":"Pages 328-340"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589377723000587/pdfft?md5=1ab1b4ea1cf4e1cc548df57b29f2697e&pid=1-s2.0-S2589377723000587-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138395703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Croton hirtus attenuating streptozotocin-induced neuroinflammation in rats 巴豆对链脲佐菌素所致大鼠神经炎症的减毒作用
Q3 Medicine Pub Date : 2023-09-01 DOI: 10.1016/j.dcmed.2023.10.005
Prakash Ramakrishnan , Jayaram Rajangam , Binoy Varghese Cherian , Jose Prakash Dharmian

Objective

The present study was aimed to investigate the neuroprotective effect of Croton hirtus (CH) extract against streptozotocin (STZ) in rats.

Methods

(i) The sub-chronic toxicity consisted of 24 adult rats of either sex weighing from 160 to 200 g were divided into four groups with six rats in each group. Rats in group 1 received Dimethyl sulfoxide (DMSO) mixed with saline; rats in groups 2, 3, and 4 received 100, 200, and 400 mg/kg of methanolic extract of CH (MECH) orally by gavage administration for 28 d, respectively. The functional observation battery and locomotor activity were graded as part of their neurobehavioral activity and the brain regions, including cortex and hippocampus, were analyzed for neuropathological abnormalities. (ii) The main research consisted of 30 adult male Wistar rats weighing from 160 to 200 g, which were divided into five groups and six rats in each group, including control (I), STZ (II), Donepezil (III), MECH (100 mg/kg, IV), and MECH (200 mg/kg, V) groups. Rats in group I received citrate buffer orally and DMSO mixed with saline for 14 d. Rats in group II received STZ via intracerebroventricular injection (3 mg/kg, bilateral ICV-STZ) on days 1 and 3 followed by DMSO mixed with saline for 14 d. Rats in groups III, IV, and V received STZ administration on days 1 and 3 followed by Donepezil [3 mg/(kg·d), p.o.] and MECH [100 and 200 mg/(kg·d), p.o.] for 14 d. Rats were tested for learning and memory parameters such as Morris water maze (MWM) and passive avoidance test (PAT). They were sacrificed after completing behavioural experiments; brains were harvested to estimate the acetylcholinesterase (AChE), lipid peroxidation (LPO), glutathione (GSH), and superoxide dismutase (SOD) by using UV-Visible Spectrophotometer; caspase-3 was evaluated by total fluorescence emission spectra; amyloid β (Aβ) levels were detected using enzyme-linked immuosorbent assay (ELISA); and histopathological examination was conducted in the CA1 region of the hippocampus.

Results

(i) The sub-chronic toxicity results revealed that open field test parameters including line crossing, rearing, entering the middle square, defecating, or urinating did not differ significantly in the MECH rats (P > 0.05). The histopathological observation did not show any lesions in the neuronal cells and inflammation in both the regions in MECH rats compared with control rats. (ii) The main study findings demonstrated that STZ-treated rats showed a significant increase in impairment in learning and memory parameters (P < 0.001), the levels of AChE, caspase-3, Aβ (1-40 and 1-42), and LPO were increased significantly (P < 0.001), and significant decrease was found in the levels of SOD (P < 0.001) and GSH (P < 0.01). Moreover, neuronal damage was found in the hippocampus. In contrast, STZ-induced behaviou

目的研究巴豆提取物对链脲佐菌素(STZ)的神经保护作用。方法(1)选取体重160 ~ 200 g的成年雌雄大鼠24只,随机分为4组,每组6只。1组大鼠给予二甲亚砜(DMSO)与生理盐水混合;2、3、4组大鼠分别灌胃给药100、200、400 mg/kg的甲醇提取物(MECH)。将功能观察电池和运动活动作为神经行为活动的一部分进行分级,并分析包括皮质和海马在内的大脑区域的神经病理异常。(ii)选取体重160 ~ 200 g的成年雄性Wistar大鼠30只,随机分为5组,每组6只,分别为对照组(I)、STZ (ii)、多奈哌齐(III)、MECH (100 mg/kg, IV)和MECH (200 mg/kg, V)组。ⅰ组大鼠口服枸橼酸缓冲液和DMSO与生理盐水混合14 d,ⅱ组大鼠第1、3天通过脑室内注射STZ (3 mg/kg,双侧ICV-STZ),第14天通过DMSO与生理盐水混合给药。ⅲ、IV、V组大鼠第1、3天给予STZ,随后给予多内哌齐[3 mg/(kg·d), p.o]和MECH[100、200 mg/(kg·d)],采用Morris水迷宫(MWM)和被动回避测试(PAT)对大鼠进行学习记忆测试。他们在完成行为实验后被处死;采集脑组织,用紫外可见分光光度计测定乙酰胆碱酯酶(AChE)、脂质过氧化(LPO)、谷胱甘肽(GSH)和超氧化物歧化酶(SOD);用总荧光发射光谱评价Caspase-3;采用酶联免疫吸附法(ELISA)检测β淀粉样蛋白(Aβ)水平;结果(i)亚慢性毒性实验结果显示,MECH大鼠的交叉、饲养、进入中方、排便、排尿等开放性实验参数无显著差异(P >0.05)。组织病理学观察显示,与对照组相比,MECH大鼠的神经细胞未见任何病变,两区均未出现炎症反应。(ii)主要研究结果显示,stz处理大鼠的学习记忆参数损伤显著增加(P <0.001), AChE、caspase-3、Aβ(1-40和1-42)和LPO水平显著升高(P <0.001), SOD水平显著降低(P <0.001)和谷胱甘肽(P <0.01)。此外,海马中还发现了神经元损伤。相比之下,stz诱导的大鼠行为和生化损伤与MECH剂量依赖性显著降低。结论mech对STZ诱导的大鼠记忆缺损具有明显的抗氧化作用。胆碱能功能的恢复可能是行为改善的原因。因此,MECH可能能够治疗认知障碍,如阿尔茨海默病(AD)。
{"title":"Croton hirtus attenuating streptozotocin-induced neuroinflammation in rats","authors":"Prakash Ramakrishnan ,&nbsp;Jayaram Rajangam ,&nbsp;Binoy Varghese Cherian ,&nbsp;Jose Prakash Dharmian","doi":"10.1016/j.dcmed.2023.10.005","DOIUrl":"https://doi.org/10.1016/j.dcmed.2023.10.005","url":null,"abstract":"<div><h3>Objective</h3><p>The present study was aimed to investigate the neuroprotective effect of <em>Croton hirtus</em> (CH) extract against streptozotocin (STZ) in rats.</p></div><div><h3>Methods</h3><p>(i) The sub-chronic toxicity consisted of 24 adult rats of either sex weighing from 160 to 200 g were divided into four groups with six rats in each group. Rats in group 1 received Dimethyl sulfoxide (DMSO) mixed with saline; rats in groups 2, 3, and 4 received 100, 200, and 400 mg/kg of methanolic extract of CH (MECH) orally by gavage administration for 28 d, respectively. The functional observation battery and locomotor activity were graded as part of their neurobehavioral activity and the brain regions, including cortex and hippocampus, were analyzed for neuropathological abnormalities. (ii) The main research consisted of 30 adult male Wistar rats weighing from 160 to 200 g, which were divided into five groups and six rats in each group, including control (I), STZ (II), Donepezil (III), MECH (100 mg/kg, IV), and MECH (200 mg/kg, V) groups. Rats in group I received citrate buffer orally and DMSO mixed with saline for 14 d. Rats in group II received STZ via intracerebroventricular injection (3 mg/kg, bilateral ICV-STZ) on days 1 and 3 followed by DMSO mixed with saline for 14 d. Rats in groups III, IV, and V received STZ administration on days 1 and 3 followed by Donepezil [3 mg/(kg·d), p.o.] and MECH [100 and 200 mg/(kg·d), p.o.] for 14 d. Rats were tested for learning and memory parameters such as Morris water maze (MWM) and passive avoidance test (PAT). They were sacrificed after completing behavioural experiments; brains were harvested to estimate the acetylcholinesterase (AChE), lipid peroxidation (LPO), glutathione (GSH), and superoxide dismutase (SOD) by using UV-Visible Spectrophotometer; caspase-3 was evaluated by total fluorescence emission spectra; amyloid <em>β</em> (A<em>β</em>) levels were detected using enzyme-linked immuosorbent assay (ELISA); and histopathological examination was conducted in the CA1 region of the hippocampus.</p></div><div><h3>Results</h3><p>(i) The sub-chronic toxicity results revealed that open field test parameters including line crossing, rearing, entering the middle square, defecating, or urinating did not differ significantly in the MECH rats (<em>P</em> &gt; 0.05). The histopathological observation did not show any lesions in the neuronal cells and inflammation in both the regions in MECH rats compared with control rats. (ii) The main study findings demonstrated that STZ-treated rats showed a significant increase in impairment in learning and memory parameters (<em>P</em> &lt; 0.001), the levels of AChE, caspase-3, A<em>β</em> (1-40 and 1-42), and LPO were increased significantly (<em>P</em> &lt; 0.001), and significant decrease was found in the levels of SOD (<em>P</em> &lt; 0.001) and GSH (<em>P</em> &lt; 0.01). Moreover, neuronal damage was found in the hippocampus. In contrast, STZ-induced behaviou","PeriodicalId":33578,"journal":{"name":"Digital Chinese Medicine","volume":"6 3","pages":"Pages 295-306"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589377723000551/pdfft?md5=9e59cc4b8f715c1c1bb16398c44a8ffe&pid=1-s2.0-S2589377723000551-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138335255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhibition of photoreceptor apoptosis in mice with retinitis pigmentosa through NF-κB/NLRP3 pathway suppression with Lycium barbarum polysaccharide 枸杞多糖通过抑制NF-κB/NLRP3通路抑制色素性视网膜炎小鼠光受体凋亡
Q3 Medicine Pub Date : 2023-09-01 DOI: 10.1016/j.dcmed.2023.10.006
Ying Wang , Ying Deng , Jing Lu , Jun Peng , Yasha Zhou , Yijing Yang , Qinghua Peng

Objective

To explore whether Lycium barbarum polysaccharide (LBP) can reduce the apoptosis of retinal photoreceptor cells in retinitis pigmentosa (RP) mice by inhibiting nuclear factor-kappa B (NF-κB)/NOD-like receptor thermal protein domain-associated protein 3 (NLRP3) signaling pathway.

Methods

(i) In vitro experiments, mouse retinal ganglion cells (661W cells) were divided into normal, model, LBP low-dose (LBP-L, 40 mg/L), LBP middle-dose (LBP-M, 80 mg/L), LBP high-dose (LBP-H, 160 mg/L), and positive drug control (NLRP3 inhibitor, 160 mg/L) groups. And the 661W cells were exposed to varying concentrations of H2O2 ranging from 50 to 400 μmol/L to determine the optimal concentration for inducing apoptosis (200 μmol/L). Then the cell viability was assessed using Cell Counting Kit-8 (CCK-8), while the apoptosis rate was detected by flow cytometry; the expression of NLRP3 was detected by immunofluorescence; and the expression of apoptosis markers was detected by enzyme-linked immunosorbent assay (ELISA) and Western blot (WB). (ii) In vivo assays were carried out with the use of C57/BL6 and Rd10 mice. The animal experimental groups were divided into normal, model, LBP-L, LBP-M, LBP-H, and NLRP3 inhibitor groups, in which the normal group was C57/BL6 mice and the other groups were Rd10 mice. Ten mice were included in each group, and the corresponding drugs were administered intragastrically for a duration of four weeks. NF-κB/NLRP3 pathway and the expression of apoptosis markers were observed by electroretinogram, histopathological examination, and WB to assess the effects of LBP on retinal photoreceptor cell apoptosis.

Results

(i) In vitro experiments, compared with the normal group, the apoptosis rate of 661W cells in model group was significantly increased (P < 0.01), and the expression levels of key proteins of NF-κB/NLRP pathway, such as NLRP3, NF-κB, p-NF-κB, and pro-apoptotic protein caspase-3, were up-regulated (P < 0.01). The rate of Bax/Bcl-2 was increased (P < 0.01), and the concentrations of interleukin (IL)-1β and tumor necrosis factor (TNF)-α were significantly increased (P < 0.01). Compared with the model group, high dose of LBP decreased the apoptosis rate of 661W cells (P < 0.01), and down-regulated the expression levels of the key proteins of NF-κB/NLRP3 pathway, including NF-κB, NLRP3, p-NF-κB, and caspase-3 (P < 0.01). The rate of Bax/Bcl-2 was decreased (P < 0.01), and the concentrations of IL-1β and TNF-α were decreased (P < 0.01). (ii) In vivo experiments, high dose of LBP significantly increased morphological changes in the outer nuclear layer (ONL) thickness of Rd10 mice, as well as functional

目的探讨枸杞多糖(LBP)能否降低视网膜感光细胞的凋亡在小鼠视网膜色素变性(RP)通过抑制核factor-kappa B (NF -κB) /热蛋白质domain-associated nod样受体3 (NLRP3)信号pathway.Methods (i)在体外实验中,小鼠视网膜神经节细胞(661 w细胞)被分成正常模型,枸杞多糖低剂量(LBP-L 40 mg / L),枸杞多糖中(LBP-M, 80 mg / L),枸杞多糖高剂量(LBP-H, 160 mg / L),阳性药物对照(NLRP3抑制剂,160 mg/L)组。将661W细胞暴露于50 ~ 400 μmol/L不同浓度的H2O2中,确定诱导细胞凋亡的最佳浓度(200 μmol/L)。采用细胞计数试剂盒-8 (CCK-8)检测细胞活力,流式细胞术检测细胞凋亡率;免疫荧光法检测NLRP3的表达;采用酶联免疫吸附法(ELISA)和免疫印迹法(WB)检测细胞凋亡标志物的表达。(ii)采用C57/BL6和Rd10小鼠进行体内实验。动物实验组分为正常组、模型组、LBP-L组、LBP-M组、LBP-H组、NLRP3抑制剂组,其中正常组为C57/BL6小鼠,其余组为Rd10小鼠。每组10只小鼠,灌胃相应药物,持续4周。通过视网膜电图、组织病理学检查、WB观察LBP对大鼠视网膜感光细胞凋亡的影响,观察NF-κB/NLRP3通路及凋亡标志物的表达情况。结果(i)体外实验,与正常组比较,模型组661W细胞凋亡率显著升高(P <0.01), NF-κB/NLRP通路关键蛋白NLRP3、NF-κB、P -NF-κB、促凋亡蛋白caspase-3表达水平上调(P <0.01)。Bax/Bcl-2比值升高(P <0.01),白细胞介素(IL)-1β和肿瘤坏死因子(TNF)-α浓度显著升高(P <0.01)。与模型组比较,高剂量LBP可降低661W细胞的凋亡率(P <0.01),并下调NF-κB/NLRP3通路关键蛋白NF-κB、NLRP3、P -NF-κB、caspase-3的表达水平(P <0.01)。Bax/Bcl-2比值降低(P <0.01), IL-1β和TNF-α浓度降低(P <0.01)。(ii)体内实验中,高剂量LBP显著增加了Rd10小鼠外核层(ONL)厚度的形态学改变,以及a波和b波振幅的功能改变(P <0.01),同时下调NF-κB的表达水平(P <0.05)、NLRP3、P - nf -κB、caspase-3 (P <0.01),降低Bax/Bcl-2率(P <0.01), IL-1β浓度降低(P <0.01)和TNF-α (P <0.05)。结论lbp可改善视网膜形态和功能,通过抑制NF-κB/NLRP3通路保护光感受器细胞凋亡。
{"title":"Inhibition of photoreceptor apoptosis in mice with retinitis pigmentosa through NF-κB/NLRP3 pathway suppression with Lycium barbarum polysaccharide","authors":"Ying Wang ,&nbsp;Ying Deng ,&nbsp;Jing Lu ,&nbsp;Jun Peng ,&nbsp;Yasha Zhou ,&nbsp;Yijing Yang ,&nbsp;Qinghua Peng","doi":"10.1016/j.dcmed.2023.10.006","DOIUrl":"https://doi.org/10.1016/j.dcmed.2023.10.006","url":null,"abstract":"<div><h3>Objective</h3><p>To explore whether <em>Lycium barbarum</em> polysaccharide (LBP) can reduce the apoptosis of retinal photoreceptor cells in retinitis pigmentosa (RP) mice by inhibiting nuclear factor-kappa B (NF-<em>κ</em>B)/NOD-like receptor thermal protein domain-associated protein 3 (NLRP3) signaling pathway.</p></div><div><h3>Methods</h3><p>(i) <em>In vitro</em> experiments, mouse retinal ganglion cells (661W cells) were divided into normal, model, LBP low-dose (LBP-L, 40 mg/L), LBP middle-dose (LBP-M, 80 mg/L), LBP high-dose (LBP-H, 160 mg/L), and positive drug control (NLRP3 inhibitor, 160 mg/L) groups. And the 661W cells were exposed to varying concentrations of H<sub>2</sub>O<sub>2</sub> ranging from 50 to 400 μmol/L to determine the optimal concentration for inducing apoptosis (200 μmol/L). Then the cell viability was assessed using Cell Counting Kit-8 (CCK-8), while the apoptosis rate was detected by flow cytometry; the expression of NLRP3 was detected by immunofluorescence; and the expression of apoptosis markers was detected by enzyme-linked immunosorbent assay (ELISA) and Western blot (WB). (ii) <em>In vivo</em> assays were carried out with the use of C57/BL6 and Rd10 mice. The animal experimental groups were divided into normal, model, LBP-L, LBP-M, LBP-H, and NLRP3 inhibitor groups, in which the normal group was C57/BL6 mice and the other groups were Rd10 mice. Ten mice were included in each group, and the corresponding drugs were administered intragastrically for a duration of four weeks. NF-<em>κ</em>B/NLRP3 pathway and the expression of apoptosis markers were observed by electroretinogram, histopathological examination, and WB to assess the effects of LBP on retinal photoreceptor cell apoptosis.</p></div><div><h3>Results</h3><p>(i) <em>In vitro</em> experiments, compared with the normal group, the apoptosis rate of 661W cells in model group was significantly increased (<em>P</em> &lt; 0.01), and the expression levels of key proteins of NF-<em>κ</em>B/NLRP pathway, such as NLRP3, NF-<em>κ</em>B, p-NF-<em>κ</em>B, and pro-apoptotic protein caspase-3, were up-regulated (<em>P</em> &lt; 0.01). The rate of Bax/Bcl-2 was increased (<em>P</em> &lt; 0.01), and the concentrations of interleukin (IL)-1<em>β</em> and tumor necrosis factor (TNF)-<em>α</em> were significantly increased (<em>P</em> &lt; 0.01). Compared with the model group, high dose of LBP decreased the apoptosis rate of 661W cells (<em>P</em> &lt; 0.01), and down-regulated the expression levels of the key proteins of NF-<em>κ</em>B/NLRP3 pathway, including NF-<em>κ</em>B, NLRP3, p-NF-<em>κ</em>B, and caspase-3 (<em>P</em> &lt; 0.01). The rate of Bax/Bcl-2 was decreased (<em>P</em> &lt; 0.01), and the concentrations of IL-1<em>β</em> and TNF-<em>α</em> were decreased (<em>P</em> &lt; 0.01). (ii) <em>In vivo</em> experiments, high dose of LBP significantly increased morphological changes in the outer nuclear layer (ONL) thickness of Rd10 mice, as well as functional ","PeriodicalId":33578,"journal":{"name":"Digital Chinese Medicine","volume":"6 3","pages":"Pages 307-316"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589377723000563/pdfft?md5=207e252e42ac4112582b53caf0987ee7&pid=1-s2.0-S2589377723000563-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138390010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medication rule and mechanism of traditional Chinese medicine in treating metabolism-associated fatty liver disease based on bioinformatics technology 基于生物信息学技术的中药治疗代谢相关性脂肪肝的用药规律及机制研究
Q3 Medicine Pub Date : 2023-09-01 DOI: 10.1016/j.dcmed.2023.10.002
Zhang Yunkun , Yao Rong , Li Lin , Li Wenli , Li Changqing , Pan Yu , Li Shunxiang

[Objective]

To analyze the main syndrome types, medication rules, and core prescription characteristics of traditional Chinese medicine (TCM) in the treatment of metabolism-associated fatty liver disease (MAFLD), and to predict the anti-MAFLD mechanism of core formula, so as to provide references for the clinical application of TCM and the development of new drugs.

[Methods]

Literature research on TCM in treating MAFLD was retrieved from China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), and Wanfang Database since the establishment of the database to July 2022. Excel 2019 and Chinese Medicine Inheritance Computing Platform (V3.0) were used for frequency analysis, association rule analysis, and cluster analysis of effective prescriptions. The key components, targets, and action pathways of anti-MAFLD core formulas were predicted by network pharmacology. Finally, the interactions between the obtained core components and their core targets were verified reversely by molecular docking technology.

[Results]

A total of 218 articles were screened and selected, including 352 prescriptions, involving 270 traditional Chinese herbs. The drugs were used a total of 3 901 times, and a total of 10 915 cases were collected, among which the prevalence rate was higher in males. The main types of TCM syndrome included intermingled phlegm and blood stasis syndrome, liver depression and spleen deficiency syndrome, and damp-heat in liver and gallbladder syndrome, among which Shanzha (Crataegi Fructus), Danshen (Salviae Miltiorrhizae Radix et Rhizoma), Fuling (Poria), Zexie (Alismatis Rhizoma), Chaihu (Bupleuri Radix), and Baizhu (Atractylodis Macrocephalae Rhizoma) were the most frequently used. The properties of Chinese medicine primarily encompassed thermal characteristics, with a predominant emphasis on cold and warm; the flavors of herbs were predominantly characterized by bitterness and sweetness, while the majority exhibited tropism towards the spleen and liver meridians. The drugs were primarily classified based on their efficacy in tonifying deficiencies, promoting diuresis and moistening, enhancing blood circulation and removing blood stasis, heat-clearing, etc. The association rules were employed to derive a set of 20 core drug pairs, while cluster analysis was utilized to identify three distinct groups of core drug combinations. Network pharmacological showed that the main components of the core formula “Shanzha (Crataegi Fructus) - Danshen (Salviae Miltiorrhizae Radix et Rhizoma) - Zexie (Alismatis Rhizoma) - Chaihu (Bupleuri Radix) - Fuling (Poria)” in the treatment of MAFLD were quercetin, apigenin, puerarin, luteolin, ursolic acid, kaempferol, tanshinone IIA, emodin, paeonol, etc., which involved RAC-alpha serine/threonine-protein kinase 1 (AKT1), cellular tumor antigen p53 (TP53), interleukin (IL)-6, IL-1β, signal transducer and

【目的】分析中医治疗代谢相关性脂肪肝(MAFLD)的主要证候类型、用药规律及核心方剂特点,预测核心方剂抗MAFLD的作用机制,为中医临床应用及新药开发提供参考。【方法】检索中国知网(CNKI)、中国科技期刊数据库(VIP)和万方数据库自数据库建立以来至2022年7月的中医药治疗MAFLD的文献研究。使用Excel 2019和中药传承计算平台(V3.0)对有效处方进行频次分析、关联规则分析和聚类分析。利用网络药理学方法预测抗mafld核心方的关键成分、靶点和作用途径。最后,通过分子对接技术反向验证获得的核心组分与其核心靶点之间的相互作用。【结果】共筛选文献218篇,处方352张,涉及中草药270种。共使用药物3 901次,共收集病例10 915例,其中男性患病率较高。中医证型主要有痰瘀混证、肝郁脾虚证、肝胆湿热证,其中以山楂、丹参、茯苓、泽泻、柴胡、白术最为常用。中医的特性主要包括热特性,主要强调冷和暖;中草药味以苦、甜为主,多数呈脾、肝经偏性。主要根据补虚、利尿润润、活血化瘀、清热等功效进行分类。利用关联规则推导出一组20个核心药物对,并利用聚类分析识别出三组不同的核心药物组合。网络药理表明主要组件的核心公式”Shanzha (Crataegi果实)——丹参(Salviae中药)Miltiorrhizae——Zexie (Alismatis根茎)——Chaihu (Bupleuri基数)——涪陵(云苓)”治疗MAFLD槲皮素,芹黄素,葛根素,毛地黄黄酮,乌索酸、山柰酚、tanshinone活动花絮,大黄素、芍药醇,等等,涉及RAC-alpha丝氨酸/ threonine-protein激酶1 (AKT1),细胞p53肿瘤抗原(TP53)、白介素(IL) 6、IL - 1β,信号转导和转录激活因子3 (STAT3)、表皮生长因子受体(EGFR)、过氧化物酶体增殖激活受体γ (PPARG)等关键靶点。分子对接结果显示,核心组分与脂质、动脉粥样硬化、磷脂酰肌醇3激酶(PI3K)/AKT信号通路相关蛋白结合良好。【结论】中医治疗mld的主要原则是健肝健脾、化痰湿、清热湿、活血化瘀。核心配方可能通过多种成分、靶点和信号通路介导发挥抗mafld作用。本研究为中医药治疗mald的临床应用奠定了理论基础,并为进一步开发mald新药提供了参考。
{"title":"Medication rule and mechanism of traditional Chinese medicine in treating metabolism-associated fatty liver disease based on bioinformatics technology","authors":"Zhang Yunkun ,&nbsp;Yao Rong ,&nbsp;Li Lin ,&nbsp;Li Wenli ,&nbsp;Li Changqing ,&nbsp;Pan Yu ,&nbsp;Li Shunxiang","doi":"10.1016/j.dcmed.2023.10.002","DOIUrl":"https://doi.org/10.1016/j.dcmed.2023.10.002","url":null,"abstract":"<div><h3>[Objective]</h3><p>To analyze the main syndrome types, medication rules, and core prescription characteristics of traditional Chinese medicine (TCM) in the treatment of metabolism-associated fatty liver disease (MAFLD), and to predict the anti-MAFLD mechanism of core formula, so as to provide references for the clinical application of TCM and the development of new drugs.</p></div><div><h3>[Methods]</h3><p>Literature research on TCM in treating MAFLD was retrieved from China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), and Wanfang Database since the establishment of the database to July 2022. Excel 2019 and Chinese Medicine Inheritance Computing Platform (V3.0) were used for frequency analysis, association rule analysis, and cluster analysis of effective prescriptions. The key components, targets, and action pathways of anti-MAFLD core formulas were predicted by network pharmacology. Finally, the interactions between the obtained core components and their core targets were verified reversely by molecular docking technology.</p></div><div><h3>[Results]</h3><p>A total of 218 articles were screened and selected, including 352 prescriptions, involving 270 traditional Chinese herbs. The drugs were used a total of 3 901 times, and a total of 10 915 cases were collected, among which the prevalence rate was higher in males. The main types of TCM syndrome included intermingled phlegm and blood stasis syndrome, liver depression and spleen deficiency syndrome, and damp-heat in liver and gallbladder syndrome, among which Shanzha (Crataegi Fructus), Danshen (Salviae Miltiorrhizae Radix et Rhizoma), Fuling (Poria), Zexie (Alismatis Rhizoma), Chaihu (Bupleuri Radix), and Baizhu (Atractylodis Macrocephalae Rhizoma) were the most frequently used. The properties of Chinese medicine primarily encompassed thermal characteristics, with a predominant emphasis on cold and warm; the flavors of herbs were predominantly characterized by bitterness and sweetness, while the majority exhibited tropism towards the spleen and liver meridians. The drugs were primarily classified based on their efficacy in tonifying deficiencies, promoting diuresis and moistening, enhancing blood circulation and removing blood stasis, heat-clearing, etc. The association rules were employed to derive a set of 20 core drug pairs, while cluster analysis was utilized to identify three distinct groups of core drug combinations. Network pharmacological showed that the main components of the core formula “Shanzha (Crataegi Fructus) - Danshen (Salviae Miltiorrhizae Radix et Rhizoma) - Zexie (Alismatis Rhizoma) - Chaihu (Bupleuri Radix) - Fuling (Poria)” in the treatment of MAFLD were quercetin, apigenin, puerarin, luteolin, ursolic acid, kaempferol, tanshinone IIA, emodin, paeonol, etc., which involved RAC-alpha serine/threonine-protein kinase 1 (AKT1), cellular tumor antigen p53 (TP53), interleukin (IL)-6, IL-1<em>β</em>, signal transducer and ","PeriodicalId":33578,"journal":{"name":"Digital Chinese Medicine","volume":"6 3","pages":"Pages 257-271"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589377723000526/pdfft?md5=206c27be40ee42f6346f7000f05c688b&pid=1-s2.0-S2589377723000526-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138390011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bibliometric analysis on research hotspots and evolutionary trends of artificial intelligence application in traditional Chinese medicine diagnosis 人工智能在中医诊断中的应用研究热点及发展趋势的文献计量分析
Q3 Medicine Pub Date : 2023-06-01 DOI: 10.1016/j.dcmed.2023.07.004
Zhang Jieyi , Peng Qinghua , Yan Junfeng

Objective

To explore the development and research hotspots on the application of artificial intelligence (AI) in traditional Chinese medicine (TCM) diagnosis and predict research trends in the area.

Methods

All articles were retrieved from China National Knowledge Infrastructure (CNKI), Wanfang Data (Wanfang), China Science and Technology Journal Database (VIP), and Web of Science Core Collection (WoSCC). All related papers published in journals from the foundation of the databases to December 31, 2022 were included. NoteExpress, Co-Occurrence (COOC), VOSviewer, and CiteSpace were used to visualize data about publication volumes, journals, authors, research institutions, and keywords as well as to analyze hotspots trending topics in the field.

Results

A total of 686 articles were retrieved from the databases, among which 610 papers were published in Chinese and 76 in English. In terms of the journals in which these papers were published, 238 of them were Chinese journals and 52 were English ones. The number of the papers published in journals presented a slow growth. According to the results from Chinese article analysis, WANG Yiqin from Shanghai University of Traditional Chinese Medicine published the most papers in the field. The authors of Chinese papers belonged to six long-term research teams, led by WANG Yiqin and XU Jiatuo (Shanghai University of Traditional Chinese Medicine), WEI Yuke (Guangdong University of Technology), LI Gang (Tianjin University), XI Guangcheng (Institute of Automation of the Chinese Academy of Sciences), and NIU Xin (Beijing University of Chinese Medicine), respectively. In accordance with results from English paper analysis, four authors equally publishing the most papers were YAN Haixia, HU Xiaojuan, and JIANG Tao (Shanghai University of Traditional Chinese Medicine), and WEN Chuanbiao (Chengdu University of Traditional Chinese Medicine). The authors of English papers were from two major research teams in the field of Shanghai University of Traditional Chinese Medicine. Currently, research hotspots on AI such as neural networks, data mining, machine learning, feature recognition, image processing, and expert systems, have been centered on tongue diagnosis, pulse diagnosis, and syndrome research in TCM. Additionally, it was found that research on the topic was gradually evolving from explorations of a single diagnosis method to investigations on the combination of multiple TCM diagnosis methods.

Conclusion

Research on AI application in TCM diagnosis is still in a slowly growing stage. As technology develops, AI has been applied to many aspects of TCM diagnosis. Therefore, how to combine the two for improving TCM diagnosis is something worthy of our brainstorming and exploring.

目的探讨人工智能在中医诊断中应用的发展和研究热点,并预测该领域的研究趋势。方法检索中国知网(CNKI)、万方数据(Wanfang Data)、中国科技期刊数据库(VIP)和网络科学核心库(WoSCC)中的所有文章。从数据库成立到2022年12月31日,所有发表在期刊上的相关论文都被收录在内。NoteExpress、CoOccurrence(COOC)、VOSviewer和CiteSpace用于可视化有关出版量、期刊、作者、研究机构和关键词的数据,并分析该领域的热点趋势主题。结果从数据库中检索到686篇文章,其中中文610篇,英文76篇。就发表这些论文的期刊而言,其中238种是中文期刊,52种是英文期刊。发表在期刊上的论文数量增长缓慢。根据中文文章分析结果,上海中医药大学的王益勤是该领域发表论文最多的学者。中国论文作者隶属于六个长期研究团队,分别由上海中医药大学的王毅勤和徐家沱、广东工业大学的魏玉科、天津大学的李刚、中国科学院自动化研究所的XI光诚和北京中医药大学的倪欣领导。根据英文论文分析结果,发表论文最多的四位作者分别是上海中医药大学的严海霞、胡晓娟和姜涛,以及成都中医药大学文传标。英文论文的作者来自上海中医药大学领域的两个主要研究团队。目前,人工智能的研究热点,如神经网络、数据挖掘、机器学习、特征识别、图像处理和专家系统,一直集中在中医的舌诊、脉诊和证候研究上。此外,研究发现,该主题的研究正逐渐从单一诊断方法的探索发展到多种中医诊断方法的结合研究。结论人工智能在中医诊断中的应用研究仍处于缓慢发展阶段。随着技术的发展,人工智能已经应用于中医诊断的许多方面。因此,如何将两者结合起来,提高中医诊断水平,是值得我们集思广益和探索的。
{"title":"Bibliometric analysis on research hotspots and evolutionary trends of artificial intelligence application in traditional Chinese medicine diagnosis","authors":"Zhang Jieyi ,&nbsp;Peng Qinghua ,&nbsp;Yan Junfeng","doi":"10.1016/j.dcmed.2023.07.004","DOIUrl":"https://doi.org/10.1016/j.dcmed.2023.07.004","url":null,"abstract":"<div><h3>Objective</h3><p>To explore the development and research hotspots on the application of artificial intelligence (AI) in traditional Chinese medicine (TCM) diagnosis and predict research trends in the area.</p></div><div><h3>Methods</h3><p>All articles were retrieved from China National Knowledge Infrastructure (CNKI), Wanfang Data (Wanfang), China Science and Technology Journal Database (VIP), and Web of Science Core Collection (WoSCC). All related papers published in journals from the foundation of the databases to December 31, 2022 were included. NoteExpress, Co-Occurrence (COOC), VOSviewer, and CiteSpace were used to visualize data about publication volumes, journals, authors, research institutions, and keywords as well as to analyze hotspots trending topics in the field.</p></div><div><h3>Results</h3><p>A total of 686 articles were retrieved from the databases, among which 610 papers were published in Chinese and 76 in English. In terms of the journals in which these papers were published, 238 of them were Chinese journals and 52 were English ones. The number of the papers published in journals presented a slow growth. According to the results from Chinese article analysis, WANG Yiqin from Shanghai University of Traditional Chinese Medicine published the most papers in the field. The authors of Chinese papers belonged to six long-term research teams, led by WANG Yiqin and XU Jiatuo (Shanghai University of Traditional Chinese Medicine), WEI Yuke (Guangdong University of Technology), LI Gang (Tianjin University), XI Guangcheng (Institute of Automation of the Chinese Academy of Sciences), and NIU Xin (Beijing University of Chinese Medicine), respectively. In accordance with results from English paper analysis, four authors equally publishing the most papers were YAN Haixia, HU Xiaojuan, and JIANG Tao (Shanghai University of Traditional Chinese Medicine), and WEN Chuanbiao (Chengdu University of Traditional Chinese Medicine). The authors of English papers were from two major research teams in the field of Shanghai University of Traditional Chinese Medicine. Currently, research hotspots on AI such as neural networks, data mining, machine learning, feature recognition, image processing, and expert systems, have been centered on tongue diagnosis, pulse diagnosis, and syndrome research in TCM. Additionally, it was found that research on the topic was gradually evolving from explorations of a single diagnosis method to investigations on the combination of multiple TCM diagnosis methods.</p></div><div><h3>Conclusion</h3><p>Research on AI application in TCM diagnosis is still in a slowly growing stage. As technology develops, AI has been applied to many aspects of TCM diagnosis. Therefore, how to combine the two for improving TCM diagnosis is something worthy of our brainstorming and exploring.</p></div>","PeriodicalId":33578,"journal":{"name":"Digital Chinese Medicine","volume":"6 2","pages":"Pages 136-150"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49727085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medication and prescription rules for treating spleen and stomach diseases in Prescriptions of Peaceful Benevolent Dispensary 《和平仁政药方》中脾胃疾病的用药及方剂规则
Q3 Medicine Pub Date : 2023-06-01 DOI: 10.1016/j.dcmed.2023.07.012
Yao Shuaijun , Yang Jihong , Li Peifang , Yan Jinglai

Objective

To explore the prescriptions related to the treatment of spleen and stomach diseases in Prescriptions of Peaceful Benevolent Dispensary (Tai Ping Hui Min He Ji Ju Fang,《太平惠民和剂局方》, TPHMHJJF), and investigate the medication and prescription rules.

Methods

The prescriptions of TPHMHJJF for treating spleen and stomach diseases were screened, and the data set was established by entering the prescriptions and standardized drug names using WPS Excel 2019. Herb frequency statistics, efficacy categorization, property, flavor, meridian tropism, association rules, cluster analysis, factor analysis, and complex network analysis were performed using Python 3.6.8 programming language and Gephi 0.9.2 visualization software.

Results

A total of 239 prescriptions were included after the screening, and the dosage forms were mainly pills and powders. The study involved 200 herbal medicines, among which 40 herbs had a frequency of ≥ 12. The herb with the highest frequency was Ganjiang (Zingiber Rhizoma). The herb properties were mainly warm in nature, with the most pungent herbs. Most herbs were attributed to the spleen and stomach meridians, and tonifying medicine were the main species. The association rule analysis identified 26 second-order association rules and 16 third-order association rules, with "Renshen (Ginseng Radix et Rhizoma) → Fuling (Poria)" as the leading rule in the former and "Fuling (Poria) + Baizhu (Atractylodis Macrocephalae Rhizome) → Renshen (Ginseng Radix et Rhizoma)" as the leading rule in the latter. Also, cluster analysis divided the top 30 herbs into six herb combinations that can warm the middle, move Qi, and dry dampness effectively. Factor analysis extracted 13 common factors, with Renshen (Ginseng Radix et Rhizoma), Fuling (Poria), and Baizhu (Atractylodis Macrocephalae Rhizome) as the highest contributing factors. Lastly, complex network analysis yielded the core prescription of 14 herbs, with Ganjiang (Zingiber Rhizoma), Renshen (Ginseng Radix et Rhizoma), Gancao (Glycyrrhizae Radix et Rhizome), and Chenpi (Citri Reticulatae Pericarpium) among the herbs with a higher weighting degree.

Conclusion

TPHMHJJF is mainly based on the use of warming herbs to treat spleen and stomach diseases, and its medication rule can be summarized into three aspects: (i) primarily using warming and tonifying to warm the middle and dissipate cold, (ii) using the method of moving Qi with aromatic nature to delight the spleen and appetize the stomach, and (iii) emphasizing the regulation of Qi and blood to calm the five zang-organs.

目的探讨《太平惠民和济巨方》中与脾胃病治疗有关的方剂(太平惠民合济巨方《太平惠民和剂局方》, TPHMHJJF),并研究药物和处方规则。方法筛选TPHMHJJF治疗脾胃疾病的处方,并使用WPS Excel 2019输入处方和标准化药物名称,建立数据集。使用Python 3.6.8编程语言和Gephi 0.9.2可视化软件进行草药频率统计、功效分类、性质、风味、归经、关联规则、聚类分析、因子分析和复杂网络分析。结果筛选出239个处方,剂型以丸剂和散剂为主。该研究涉及200种草药,其中40种草药的频率≥12。频率最高的是干姜。草本植物的特性主要是温暖的性质,具有最刺鼻的草本植物。大多数草药都归属于脾和胃经,而补益药是主要的种类。关联规则分析确定了26个二阶关联规则和16个三阶关联规则→ 前者以“茯苓”为主导,“茯苓+白术”为主导→ 以“人参”为主导,聚类分析将前30种药材分为温中、益气、燥湿的6个药材组合,因子分析提取了人参、茯苓、白术等13个常见因子作为最高的促成因素。最后,通过复杂网络分析得到了14种药材的核心处方,其中干姜、人参、甘草和陈皮是权重较高的药材。结论TPHMHJJF主要以温药治疗脾胃疾病为基础,其用药规律可概括为三个方面:(一)以温补温中散寒为主,以及(iii)强调调节气血以平五脏。
{"title":"Medication and prescription rules for treating spleen and stomach diseases in Prescriptions of Peaceful Benevolent Dispensary","authors":"Yao Shuaijun ,&nbsp;Yang Jihong ,&nbsp;Li Peifang ,&nbsp;Yan Jinglai","doi":"10.1016/j.dcmed.2023.07.012","DOIUrl":"https://doi.org/10.1016/j.dcmed.2023.07.012","url":null,"abstract":"<div><h3>Objective</h3><p>To explore the prescriptions related to the treatment of spleen and stomach diseases in <em>Prescriptions of Peaceful Benevolent Dispensary</em> (<em>Tai Ping Hui Min He Ji Ju Fang,</em>《太平惠民和剂局方》, TPHMHJJF), and investigate the medication and prescription rules.</p></div><div><h3>Methods</h3><p>The prescriptions of TPHMHJJF for treating spleen and stomach diseases were screened, and the data set was established by entering the prescriptions and standardized drug names using WPS Excel 2019. Herb frequency statistics, efficacy categorization, property, flavor, meridian tropism, association rules, cluster analysis, factor analysis, and complex network analysis were performed using Python 3.6.8 programming language and Gephi 0.9.2 visualization software.</p></div><div><h3>Results</h3><p>A total of 239 prescriptions were included after the screening, and the dosage forms were mainly pills and powders. The study involved 200 herbal medicines, among which 40 herbs had a frequency of ≥ 12. The herb with the highest frequency was Ganjiang (Zingiber Rhizoma). The herb properties were mainly warm in nature, with the most pungent herbs. Most herbs were attributed to the spleen and stomach meridians, and tonifying medicine were the main species. The association rule analysis identified 26 second-order association rules and 16 third-order association rules, with \"Renshen (Ginseng Radix et Rhizoma) → Fuling (Poria)\" as the leading rule in the former and \"Fuling (Poria) + Baizhu (Atractylodis Macrocephalae Rhizome) → Renshen (Ginseng Radix et Rhizoma)\" as the leading rule in the latter. Also, cluster analysis divided the top 30 herbs into six herb combinations that can warm the middle, move Qi, and dry dampness effectively. Factor analysis extracted 13 common factors, with Renshen (Ginseng Radix et Rhizoma), Fuling (Poria), and Baizhu (Atractylodis Macrocephalae Rhizome) as the highest contributing factors. Lastly, complex network analysis yielded the core prescription of 14 herbs, with Ganjiang (Zingiber Rhizoma), Renshen (Ginseng Radix et Rhizoma), Gancao (Glycyrrhizae Radix et Rhizome), and Chenpi (Citri Reticulatae Pericarpium) among the herbs with a higher weighting degree.</p></div><div><h3>Conclusion</h3><p>TPHMHJJF is mainly based on the use of warming herbs to treat spleen and stomach diseases, and its medication rule can be summarized into three aspects: (i) primarily using warming and tonifying to warm the middle and dissipate cold, (ii) using the method of moving Qi with aromatic nature to delight the spleen and appetize the stomach, and (iii) emphasizing the regulation of Qi and blood to calm the five zang-organs.</p></div>","PeriodicalId":33578,"journal":{"name":"Digital Chinese Medicine","volume":"6 2","pages":"Pages 234-244"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49749475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Digital Chinese Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1